SCHEMBL7690696

SCHEMBL7690696

O=C(CCCc1c[nH]c2ccccc12)N1CCC(CCCc2cccc3[nH]c(CCOc4ccc(Cl)cc4)nc23)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
ACHE P22303 3/20 0.44
BCHE P06276 2/20 0.44
TNKS O95271 3/20 0.43
PARP1 P09874 3/20 0.43
PARP2 Q9UGN5 3/20 0.43
HPGD P15428 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
LMNA P02545 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
PKM P14618 1/20 0.41
SLC6A4 P31645 1/20 0.40
NPY1R P25929 2/20 0.39
DRD2 P14416 1/20 0.39
GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7690701 0.79 TNKS (0.46) ALDH1A1ACHEBCHETNKSPARP1
SCHEMBL7966182 0.77 NPY1R (0.69) NPY1R
SCHEMBL7688414 0.77 NPY1R (0.51) ALDH1A1MAPTSMN1; SMN2KMT2ANPY1R
SCHEMBL8555618 0.74 NPY1R (0.46) ACHEBCHESLC6A4NPY1RDRD2
SCHEMBL7688416 0.73 NPY1R (0.70) NPY1R
SCHEMBL11240335 0.73 ALDH1A1 (0.66) ALDH1A1ACHEHPGDKDM4EMAPT
SCHEMBL6354128 0.70 SLC6A4 (0.64) ALDH1A1ACHEBCHEKMT2ASLC6A4
SCHEMBL11258267 0.69 ALDH1A1 (0.62) ALDH1A1ACHEHPGDKDM4EMAPT
SCHEMBL8554479 0.68 NPY1R (0.45) ALDH1A1MAPTLMNAKMT2ANPY1R
SCHEMBL11233886 0.68 ALDH1A1 (0.66) ALDH1A1ACHEHPGDKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020007071-A1 Benzimidzolyl neuropeptide Y receptor antagonists BRITTON THOMAS CHARLES (US) 2002-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007071-A1 Benzimidzolyl neuropeptide Y receptor antagonists NPY1R, NPY2R, NPY5R ALDH1A1 4251/4885ACHE 1970/4885BCHE 1533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.